Key points are not available for this paper at this time.
Background: Itraconazole is a widely used antifungal drug that was recently found to possess potent antiangiogenic activity. Results: We report here that itraconazole caused accumulation of immature N-glycans on VEGFR2 and inhibited VEGFR2 trafficking and signaling. Conclusion: These results suggest that itraconazole interferes with VEGFR2 trafficking, glycosylation, and signaling activity. Significance: Itraconazole possesses unique antiangiogenic potential through targeting multiple pathways that are essential for angiogenesis.
Nacev et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: